Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03624036
Title Safety and Efficacy of KTE-C19 in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia (ZUMA-8)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite, A Gilead Company
Age Groups: adult | senior
Covered Countries USA | ITA

No variant requirements are available.